$13.23
N/A
Last update: Nov 6, 4:00 PM
Adarx Pharmaceuticals Inc
ADRXNASDAQ
The average analyst price target for Adarx Pharmaceuticals is $35, 164.6% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $32 to $38. The latest change came on Oct 20, 2026, when TD Cowen initiated coverage of Adarx Pharmaceuticals with a Buy rating.
Price Target Range — 1 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
